Skip to content

Clinical trials

Phase 2 Anemia trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia Phase: Phase 2 Country / region: Australia Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20101
20132
20143
20201
20212
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Withdrawn3
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer3
GlaxoSmithKline3
BioAge Labs, Inc.2
Takeda2
Agios Pharmaceuticals, Inc.1
Hoffmann-La Roche1
Kezar Life Sciences, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia13
Renal Insufficiency, Chronic5
Thrombocytopenia2
Anemia, Hemolytic, Autoimmune1
Hematologic Diseases1
Hemolysis1
Kidney Diseases1
Myelodysplastic Syndromes1
Primary Myelofibrosis1
Purpura, Thrombocytopenic, Idiopathic1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.